WP Advisors LLC Purchases 4,068 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

WP Advisors LLC lifted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 32.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,755 shares of the exchange traded fund’s stock after acquiring an additional 4,068 shares during the period. WP Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,496,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Resources Management Corp CT ADV increased its position in shares of SPDR S&P Biotech ETF by 1,715.8% during the second quarter. Resources Management Corp CT ADV now owns 345 shares of the exchange traded fund’s stock valued at $29,000 after acquiring an additional 326 shares in the last quarter. Tyler Stone Wealth Management bought a new stake in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $33,000. EPG Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 152.7% during the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock valued at $34,000 after acquiring an additional 278 shares in the last quarter. Compass Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $34,000. Finally, Fortis Capital Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $38,000.

SPDR S&P Biotech ETF Trading Down 0.8 %

Shares of XBI stock opened at $82.83 on Friday. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The firm’s 50 day moving average is $93.52 and its 200 day moving average is $84.30. The stock has a market capitalization of $6.43 billion, a P/E ratio of 11.47 and a beta of 1.08.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Stories

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.